Antibiotic use during pregnancy and the postpartum period.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000627:therapeutic use; D002513:Cephamycins / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000517:prevention & control; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007700:Kinetics; D009582:Nitrofurantoin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011645:Puerperal Infection / Q000188:drug therapy*; D012749:Sexually Transmitted Diseases / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control; D014552:Urinary Tract Infections / Q000188:drug therapy
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D002513:Cephamycins; D010406:Penicillins; D013449:Sulfonamides; D002981:Clindamycin; D004917:Erythromycin; D009582:Nitrofurantoin